ReviewJournal of hematology & oncology2024
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer.
Weishi Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
145 papers cite itlatest 60 shown
this paperpooled itcites it